| Imiquimod | MEDICIS Pharmaceuticals | ||
| 5% Ceam; Topical |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
None | ||
|
Less Than 5
|
Less Than 5
|
||
| Used to treat certain types of growths on the skin. | |||
|
Yes
| |||
| Aldara | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ******* | *** ********* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ******* | *** ********* | ******* | ******* | ******* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* |
| **-*******[*,*-*]********-*-****** *** ********* *** | ******* ************ *** *********** ******** ******* ********** *-********-**-*******[*,*-*]********-*-***** | ****** ******** ******** ************ ********** ***** **** *** ******* | ********* *** ***** **** ********* | ****** ** ********* * ************** ***** *** ********** ********* ******** ********* | ********* ** ********* ********** ** *** ****** ***** ******* ***** **** | ****** ** ******** ********** ************ | ********* ** ********* ********** ** *** ****** ***** ******* ***** **** | ************** ***** **** ******* ********* ********** ** **** ****** ***** ******* ***** **** | ****** ** ******** * ******* ***/** ****** ********** ********* | ************** ****** **** ******* ********* ********** | ************** ****** **** ******* ***** **** | ****** ** *********** ********* | ******* *** ********* ********* ************ ** *** ******, **** ****** *** *** ****** ******* ******* *** ********** | ****** ** ********* * ************** ***** *** ********** ********* ******** ********* (** ***** **** ****** *******) | ******* *** ******** ********* ********** *** *** ******, **** ******, *** *** ****** | ******* *** *********** ********* ** ********* ********** *** *** ******, **** ******, *** *** ****** |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ******* | *** \ *** | ***, **** | ******* | ******** | ******** ** ***** **** |
| ******* | ** \ ** | ***, **** | ******* | ******** | ******** ** *** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|